Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma
|
168 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.040 | 1.000 | 4 | 2013 | 2016 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.810 | 1.000 | 3 | 2009 | 2019 | |||||
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
80 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Basal Cell Cancer
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Basal cell carcinoma
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Basal Cell Neoplasm
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Bladder Neoplasm
|
281 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1 | 2014 | 2014 | ||||||
Carcinogenesis
|
355 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Carcinoma of bladder
|
309 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.710 | 0.667 | 3 | 2010 | 2014 | |||||
Carcinoma of lung
|
1204 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.800 | 1.000 | 16 | 2008 | 2018 | |||||
Carcinoma, Basal Cell
|
91 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.740 | 1.000 | 6 | 2009 | 2017 | |||||
cervical cancer
|
268 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Cervix carcinoma
|
283 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Cleft palate with cleft lip
|
43 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.040 | 1.000 | 4 | 2013 | 2017 | |||||
Esophageal carcinoma
|
272 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Experimental Organism Basal Cell Carcinoma
|
63 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||
Head and Neck Carcinoma
|
118 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Liver carcinoma
|
942 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Lymphoma, Non-Hodgkin
|
197 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Malignant Head and Neck Neoplasm
|
118 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Malignant neoplasm of lung
|
1142 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.800 | 1.000 | 17 | 2008 | 2018 | |||||
Malignant neoplasm of pancreas
|
277 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.740 | 1.000 | 5 | 2010 | 2015 | |||||
Malignant neoplasm of skin
|
38 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.710 | 0.667 | 3 | 2010 | 2014 | |||||
Malignant Neoplasms
|
1641 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.100 | 1.000 | 11 | 2009 | 2017 |